PT  - JOURNAL ARTICLE
AU  - Chung, Christine H
AU  - Adkins, Douglas
AU  - Dimitrios Colevas, A
AU  - Rodriguez, Cristina
AU  - Park, Jong Chul
AU  - Gibson, Michael K
AU  - Sukari, Ammar
AU  - Burtness, Barbara
AU  - Johnson, Faye
AU  - Julian, Ricklie
AU  - Saba, Nabil F
AU  - Worden, Francis
AU  - Dunn, Lara A
AU  - Seiwert, Tanguy Y
AU  - Jotte, Robert M
AU  - Haddad, Rami
AU  - Gabrail, Nashat
AU  - Bauman, Julie E
AU  - Chaney, Marya
AU  - Agensky, Laura
AU  - Goel, Apollina
AU  - Quayle, Steve
AU  - Margossian, Steven
AU  - Levisetti, Matteo
AU  - Pai, Sara
TI  - 674 A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy in 3L and in combination with pembrolizumab in 1L recurrent/metastatic HPV16+ head and neck cancer patients
AID  - 10.1136/jitc-2023-SITC2023.0674
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A764--A764
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A764.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A764.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.